VRS.L

Versarien Plc
Versarien PLC - Result of General Meeting
24th March 2025, 11:24
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8931B
Versarien PLC
24 March 2025
 

24 March 2025

Versarien plc

("Versarien" or the "Company")

Result of General Meeting

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 5 March 2025 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution

 

For

 

 

Against

 

 

Abstain

1 - an ordinary resolution to grant the directors authority to allot up to 2,991,220,000 new Ordinary Shares

 

701,857,612

97%

22,360,262

3%

5,132,208

2 - a special resolution to grant the directors authority to disapply statutory pre-emption rights in respect of the allotment of up to 2,991,220,000 new Ordinary Shares

 

711,514,279

98%

11,628,884

2%

6,206,919

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0)20 3934 6630

 

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMPPUPPWUPAGGC]]>
TwitterFacebookLinkedIn